CAS RN: 4027-35-4
spiro[4.5]decan-8-one
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260205
1g / 2.5g
Out of stock
30 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 4027-35-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
4027-35-4 / spiro[4.5]decan-8-one
Standard CAS: 4027-35-4
Multi CAS: No
Basic Information
copy
CAS
4027-35-4 copy
Multi CAS
No copy
Molecular Formula
C10H16O copy
Molecular Weight
152.230000 copy
Exact Mass
152.120115 copy
InChI
InChI=1S/C10H16O/c11-9-3-7-10(8-4-9)5-1-2-6-10/h1-8H2 copy
InChIKey
DSIGHSFWYLVBJF-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
11 copy
Fraction Csp3
0.9 copy
H-bond acceptors
1 copy
Molar refractivity
44.38 copy
TPSA
17.07 copy
LogP / Solubility
WLOGP
2.69 copy
MLOGP
2.36 copy
XLogP3
2.5 copy
Consensus LogP
2.52 copy
Log S (ESOL)
-2.48 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.75 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.88 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-1.74 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2.5 copy